Haraguchi T, Kobayashi Y, Hirahara D, Kobayashi T, Takaya E, Takishita Nagai M, Tomita H, Okamoto J, Kanemaki Y, Tsugawa K.
Radiomics model of diffusion-weighted whole-body imaging with background signal suppression (DWIBS) for predicting axillary lymph node status in breast cancer.
Journal of X-Ray Science and Technology, 2023;31(3):627-640.
Koizumi T, Sugishita Y, Suzuki-TakahashiY, Nara K, Miyagawa T, Nakajima M, Sugimoto K, Futamura M, Furui T, Takai Y, Matsumoto H, Yamauchi H, Ohno S, Kataoka A, Kawai K, Fukuma E, Nogi H, Tsugawa K, Suzuki N.
Oncofertility-related psycho-educational therapy for young adult patients with breast cancer and their partners: randomized controlled trial.
Cancer, 2023;129(6):2568-2580.
Ogiya A, Nagura N, Shimo A, Nogi H, Narui K, Seki H, Mori H, Sasada S, Ishitobi M, Kondo N, Yamauchi C, Akazawa K, Shien T.
Long-Term outcomes of breast cancer patients with local recurrence after mastectomy undergoing immediate breast reconstruction- A
retrospective, multi-institutional study of 4153 cases.
Annals of surgical oncology : the official journal of the Society of Surgical Oncology, 2023;30(11):6543-6544.
Nakagawa S, Miyashita M, Maeda I, Goda A, Tada H, Amari M, Kojima Y, Tsugawa K, Ohi Y, Sagara Y, Sato M, Ebata A, Shoji NH, Suzuki T, Nakanishi M, Ohta T, Ishida T.
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma.
Breast cancer research and treatment, 2024;204:453-463.
Takenaga T, Kuji S, Tanabe K, Kanamori R, Imai H, Takeuchi J, Kondo H, Ohara T, Iwatani T, Suzuki N.
Prospective analysis of patient-reported outcomes and physician-reported outcomes with gynecologic cancer chemotherapy.
The Journal of Obstetrics and Gynaecology Research, 2024;50(1):75-85.
Goto Y, Fukuda M, Kanemaki Y.
Invesutigation of distress during diffusion-weighted whole-body magnetic resonance imaging among women with breast cancer and the effectiveness of a new technology in alleviating patient’s anxiety by approaching the human senses.
Radiography, 2024;30:634-640.
Hoshino A, Oana Y, Ohi Y, Maeda Y, Omori M, Takada Y, Ikeda T, Sotome K, Maeda H, Yanagisawa T, Takeuchi O, Kuromuma S, Sangai T, Shibahara Y, Murakuma Y, Saegusa M, Kanomata N, Satoi N, Yamaguchi R, Yoshida M, Kozuka Y, Matsumoto H, Tsugawa K, Maeda I.
Using the DNA integrity number(DIN) to analyze DNA quality in specimens collected from liquid-bases cytology after fine needle aspiration of breast tumors and lesions.
Acta cytologica, 2024;:DOI:10.1159/000538071.
② 症例報告
Nakano S, Kakimoto S, Takahashi S, Mibu A, Saigusa H.
Lymphoscintigraphy and single-photon emission computed tomography(SPECT)/CT to determine need for second sentinel lymph node biopsy
for breast cancer recurrence following lpsilateral breast/Axillary Surgery.
Amerian Journal of Case Report, 2024;25:e942424-1-e942424-7.
Takishita N M, Koike J, Kitajima M, Kuroda T, Tsuruga T, Shimo A, Shimo A, Motoyoshi A, Kojima Y, Kawamoto H, Watanabe R, Tsugawa K.
A case of umbilical serous adenocarcinoma in a breast cancer patient: A case report.
Journal of St. Marianna University, 2024;15(1):9-16.
Tazo M, Kojima Y, Tsugawa K
Predictive factors of pathologically node negative in cN+ breast cancer patients following neoadjuvant chemotherapy.
第68回国際外科学会日本部会総会, 2023.
Sugiyama R, Motoyoshi A, Ito K, Kakimoto S, Sasaki M, Sakamaki K, Kitajima M, Matsuo M, Tazo M, Kuroda T, Tsuruga T, Shimo A, Kojima Y, Nishikawa T, Tsugawa K
Contralateral risk-reduction mastectomy and patient background factors in patients with BRCA patholigical variant-positive breast cancer in our hospital.
第68回国際外科学会日本部会総会, 2023.
Motoyoshi A, Sugiyama R, Tazo M, Kojima Y, Ogiwara M, Ozawa M, Suzuki Y, Sugishita Y, Migita O, Tsugawa K
Association between patient’ background factors and contralateral risk-reduction mastectomy.
The 68th Annual Meeting of th Japan Society of Human Genetics, 2023.
② 国際学会
Kojima Y, Tsugawa K
Preveting persistent chemotherapy-induced alopecia in breast cancer patients: A trial on safety and efficacy of a novel topical treatment.
The Multinational Association of Supportive Care in Cancer, 2023.